Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2015

01-10-2015 | Article

Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media

Authors: P. Matzneller, S. Strommer, Z. Österreicher, D. Mitteregger, M. Zeitlinger

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2015

Login to get access

Abstract

Cation-dependent inhibition of antimicrobial activity was reported for polymyxin antibiotics. Ca2+ and Mg2+ concentrations recommended by the Clinical and Laboratory Standards Institute (CLSI) for the supplementation of Müller–Hinton broth (MHB) are markedly lower than interstitial space fluid (ISF) concentrations in vivo. Hence, it was speculated that the antimicrobial activity of colistin might be overestimated if tested using conventional cation-adjusted MHB. The antimicrobial activity of colistin against n = 100 clinical isolates of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae and Escherichia coli (n = 25 each) was evaluated by broth microdilution and, for selected isolates, by time–kill curves, in MHB without cations (MHBONLY), MHB supplemented with 25 mg/L Ca2+ and 12.5 mg/L Mg2+ according to CLSI recommendations (MHBCLSI), and in MHB adjusted to 50 mg/L Ca2+ and 20 mg/L Mg2+ simulating ISF concentrations (MHBISF). The minimum inhibitory concentration (MIC) values of colistin against the vast majority of isolates of both P. aeruginosa and A. baumannii increased significantly with higher cation concentrations. The susceptibility of K. pneumoniae isolates to colistin did not show significant changes between cation-supplemented media, while the MICs of E. coli decreased with ascending cation concentrations. These findings were confirmed in time–kill studies, where colistin killing against P. aeruginosa 1514 and A. baumannii 1485 declined with increasing cation concentrations. Contrarily, the killing of selected concentrations of colistin against K. pneumoniae 15 and E. coli 16 was enhanced in the presence of increasing cation concentrations. The present data suggest that the clinical antimicrobial activity of colistin might be misestimated in vitro if tested in conventional growth media.
Literature
2.
3.
go back to reference Davis SD, Iannetta A, Wedgwood RJ (1971) Activity of colistin against pseudomonas aeruginosa: inhibition by calcium. J Infect Dis 124(6):610–612CrossRefPubMed Davis SD, Iannetta A, Wedgwood RJ (1971) Activity of colistin against pseudomonas aeruginosa: inhibition by calcium. J Infect Dis 124(6):610–612CrossRefPubMed
4.
go back to reference Newton BA (1953) Reversal of the antibacterial activity of polymyxin by divalent cations. Nature 172(4369):160–161CrossRefPubMed Newton BA (1953) Reversal of the antibacterial activity of polymyxin by divalent cations. Nature 172(4369):160–161CrossRefPubMed
5.
go back to reference Clinical and Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne, PA
6.
go back to reference Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna (2014) Parameter catalogue, reference values. Home page at: http://www.kimcl.at Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna (2014) Parameter catalogue, reference values. Home page at: http://​www.​kimcl.​at
7.
go back to reference Karvanen M, Malmberg C, Mohamad A, Lagerbäck P, Friberg LE, Cars O (2011) Colistin is extensively lost during normal experimental conditions. Paper presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 2011 Karvanen M, Malmberg C, Mohamad A, Lagerbäck P, Friberg LE, Cars O (2011) Colistin is extensively lost during normal experimental conditions. Paper presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 2011
Metadata
Title
Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media
Authors
P. Matzneller
S. Strommer
Z. Österreicher
D. Mitteregger
M. Zeitlinger
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2441-7

Other articles of this Issue 10/2015

European Journal of Clinical Microbiology & Infectious Diseases 10/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine